Boston Scientific Deferred Taxes decreased by 9.1% to $220.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 41.9%, from $155.00M to $220.00M. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows a downward trend with a -7.8% CAGR.
An increase often reflects accelerated depreciation for tax purposes, which provides current cash flow benefits at the expense of future tax liabilities.
This represents the net amount of income taxes that will be payable in future periods as a result of temporary differenc...
Common in mining companies with significant capital expenditures and long-lived assets.
other_deferred_income_tax_liabilities_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $115.00M | $274.00M | $310.00M | $261.00M | $265.00M | $278.00M | $144.00M | $210.00M | $135.00M | $91.00M | $134.00M | $132.00M | $132.00M | $138.00M | $155.00M | $158.00M | $226.00M | $242.00M | $220.00M |
| QoQ Change | — | +138.3% | +13.1% | -15.8% | +1.5% | +4.9% | -48.2% | +45.8% | -35.7% | -32.6% | +47.3% | -1.5% | +0.0% | +4.5% | +12.3% | +1.9% | +43.0% | +7.1% | -9.1% |
| YoY Change | — | — | — | — | +130.4% | +1.5% | -53.5% | -19.5% | -49.1% | -67.3% | -6.9% | -37.1% | -2.2% | +51.6% | +15.7% | +19.7% | +71.2% | +75.4% | +41.9% |